Wearable Defibrillator Arrhythmia Differentiation Logic
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Prior wearable cardioverter defibrillator (WCD) systems often deliver unnecessary shocks to patients, causing disruption and loss of privacy, as they lack precise differentiation between ventricular fibrillation and ventricular tachycardia, leading to inappropriate interventions.
Innovation Solution
The WCD system implements human-perceptible indications and differential validation and confirmation criteria to distinguish between ventricular fibrillation and ventricular tachycardia, allowing for targeted shock delivery and reducing unnecessary interventions by outputting specific alerts and determining the need for shocks based on the type of arrhythmia detected.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If the WCD system delivers shocks to all detected arrhythmias to ensure patient safety, then the reliability of life-saving intervention is improved, but unnecessary shocks are delivered to conscious patients causing disruption and loss of privacy
Solution Approach 1:
The patent segments the arrhythmia detection and response process into distinct phases: detection phase, validation phase, and confirmation phase. Each phase has specific criteria that must be met before proceeding to the next, allowing the system to differentiate between true life-threatening arrhythmias and benign conditions. This segmentation enables selective shock delivery only when all criteria are satisfied, avoiding unnecessary shocks to conscious patients while maintaining reliability for genuine emergencies.
2Device complexity
If the WCD system uses a single validation criterion for all arrhythmias, then the device complexity is reduced, but the measurement precision of arrhythmia differentiation deteriorates
Solution Approach 1:
The patent applies local quality by implementing different validation and confirmation criteria tailored to specific arrhythmia types. Rather than using a uniform criterion for all detected arrhythmias, the system adjusts the criteria based on the detected rhythm characteristics. For example, ventricular fibrillation may require different validation parameters compared to ventricular tachycardia, allowing precise differentiation while managing device complexity through structured decision logic.
3Loss of information
If the WCD system implements multiple validation and confirmation criteria to reduce unnecessary shocks, then the loss of information about arrhythmia characteristics is reduced, but the device complexity increases
Solution Approach 1:
The patent employs preliminary action by establishing a structured sequence of validation and confirmation steps before shock delivery. The system pre-defines specific criteria that must be met in a predetermined order, allowing comprehensive analysis of arrhythmia characteristics without requiring complex real-time decision logic. This approach preserves critical information about the arrhythmia while managing device complexity through systematic, pre-planned evaluation protocols.
Data Source
AI summary
In some embodiments, a wearable cardioverter defibrillator (“WCD”) system comprises a support structure configured to be worn by a patient, a power source, an energy storage module configured to be coupled to the support structure, to be charged from the power source and to store an electrical charge, a discharge circuit coupled to the energy storage module, the discharge circuit controllable to discharge the electrical charge so as to cause a shock to be delivered to the patient, a measurement circuit configured to render a physiological input from a patient physiological signal, a user interface configured to output one or more human-perceptible indications, and a processor. The processor can be configured to detect a cardiac arrhythmia of the patient from the physiological input, determine whether a type of the cardiac arrhythmia is at least one of a first type (“CA1”) and a second type (“CA2”), if the type is CA1, cause a first human-perceptible indication to be output, else if the type is CA2, cause a second human-perceptible indication to be output, the second human-perceptible indication being different from the first human-perceptible indication, and then control the discharge circuit to deliver a shock responsive to the cardiac arrhythmia.